FibroGen is a company headquartered in the United States.
FibroGen (now rebranded as Kyntra Bio) is a biopharmaceutical company focused on developing therapies for serious and life-threatening diseases, including anemia and oncology.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.